vindesine has been researched along with Esophageal Neoplasms in 56 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 29 (51.79) | 18.7374 |
1990's | 23 (41.07) | 18.2507 |
2000's | 3 (5.36) | 29.6817 |
2010's | 1 (1.79) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bella, AE; Fu, JH; Hu, Y; Luo, KJ; Wen, J; Xie, X; Yang, F; Yang, H; Zhang, SS | 1 |
Hejna, M; Raderer, M | 1 |
Boku, N; Fukutomi, A; Hasuike, N; Hironaka, S; Inui, T; Ono, H; Onozawa, Y; Yamaguchi, Y; Yamazaki, K; Yasui, H; Yoshino, T | 1 |
Alexander, J; Bains, M; Chapman, R; Hilaris, B; Hopfan, S; Kelsen, DP; Martini, N; McCormack, P | 1 |
Kelsen, DP | 1 |
Bains, MS; Beattie, EJ; Kelsen, DP; Martini, N | 1 |
Bains, M; Coonley, C; Golbey, RB; Heelan, R; Hilaris, B; Kelsen, DP; Martini, N | 1 |
Bains, M; Chapman, R; Coonley, C; Dukeman, M; Heelan, R; Hilaris, B; Kelsen, D; Lesser, M | 1 |
Kelsen, D | 1 |
Bains, M; Hilaris, B; Kelsen, D; Martini, N | 1 |
Akazawa, S; Futatsuki, K; Honda, T; Sampi, K | 1 |
Akazawa, S; Fujiki, T; Fujita, K; Futatsuki, K; Kanda, Y; Kitagawa, H; Nakagawa, T; Sampi, K | 1 |
Bezwoda, WR; Derman, DP; Nissenbaum, M; Weaving, A | 1 |
Arias, F; Dominguez, MA; Illarramendi, JJ; Lopez, R; Martinez, E; Tejedor, M; Valerdi, JJ | 1 |
Ando, N; Iizuka, T; Kitajima, M; Ozawa, S | 1 |
Ashizawa, A; Katsuta, T; Kinoshita, T; Kobayashi, M; Miyahara, M; Saito, T; Shigemitsu, Y; Shimoda, K | 1 |
Hayashi, K; Ide, H | 1 |
Hirayama, K; Hoshino, A; Mori, S; Nishihira, T; Shineha, R | 1 |
Kaku, C; Kimura, O; Nabeya, K; Nakata, Y | 1 |
Fujita, H; Kakegawa, T; Shinozaki, K; Yamana, H | 1 |
Eguchi, R; Hayashi, K; Ide, H; Nakamura, T | 1 |
Furukawa, K; Hayashi, N; Itabashi, T; Morishima, Y; Nakajima, N; Nitta, H; Ohtsubo, Y; Sano, W; Sugiura, T; Takagi, K; Tashiro, T; Toyoda, Y; Yamamori, H | 1 |
Ando, N; Arimori, M; Ide, H; Iizuka, T; Ishida, K; Isono, K; Kakegawa, T; Shinoda, M; Takiyama, W; Tanaka, O; Tsugane, S; Watanabe, H | 1 |
Kobori, O; Muto, T; Nagawa, H; Seto, Y | 1 |
Aoki, K; Ikeda, K; Ishida, K; Iwaya, T; Kimura, Y; Koeda, K; Ogasawara, S; Ohtsuka, K; Saito, K; Sato, N | 1 |
Bonvoisin, S; Desseigne, F; Gerard, JP; Morignat, E; Mornex, F; Pommier, P; Taieb, S; Vaillant, E | 1 |
Isogaki, J; Kawabe, A; Kazui, T; Kobayashi, T; Nishimura, T; Nozue, M; Wada, H; Yoshida, M | 1 |
Arai, R; Ghazizadeh, M; Kawanami, O; Moriyama, Y; Obara, K; Shimizu, H; Suzuki, S; Tenjin, T | 1 |
Hikita, M; Kobayashi, M; Kohno, K; Saito, T; Sato, S; Takano, H | 1 |
Armand, JP; Bachouchi, M; Cvitkovic, E; Guillot, T; Kac, J; Luboinski, B; Munck, JN; Spielmann, M; Tellez-Bernal, E | 1 |
Iwase, H; Morise, K | 1 |
Kanamaru, R; Kikuchi, H | 1 |
Bains, M; Beitler, J; Burt, M; Chapman, D; Heelan, R; Hilaris, B; Kelsen, DP; Minsky, B; Niedzwiecki, D; Smith, M | 1 |
Hirao, E; Kinoshita, T; Kobayashi, M; Kuwahara, A; Miyahara, M; Saito, T; Shigemitsu, Y; Shimoda, K | 1 |
Endo, M; Ito, K; Sunagawa, M; Suzuki, T | 1 |
Ando, N; Ida, H; Iizuka, T; Kakegawa, T; Takagi, I; Watanabe, H | 1 |
Hattori, T; Hirai, T; Miyoshi, Y; Niimoto, M; Ohtagaki, S; Yoshihara, T | 1 |
Advani, SH; Desai, PB; Dinshaw, KA; Gopal, R; Pinto, JM; Saikia, TK; Sharma, S; Swaroop, VS; Vyas, JJ | 1 |
Bartolucci, AA; Dinwoodie, WR; Lyman, GH; Martelo, OJ; Sarma, PR; Velez-Garcia, E | 1 |
Buhr, H; Fritze, D; Herfarth, C; Herrmann, R; Schettler, G; Schlag, P | 1 |
Ikeda, K; Inada, K; Ishida, K; Mori, S; Satoh, M; Terashima, M; Yoshida, H; Yoshida, M | 1 |
Fukui, H; Hanyu, F; Ide, H; Ikemoto, H; Murata, Y; Okushima, N; Sato, Y; Yamada, A | 1 |
Herfarth, C; Herrmann, R; Lehner, B; Raeth, U; Schlag, P; Schwarz, V | 2 |
Fukui, H; Hanyu, F; Ide, H; Murata, Y; Yamada, A | 1 |
Flanagan, MM; Graeber, GM; Pass, HI; Rosenberg, JC; Roth, JA; Steinberg, S | 1 |
Kobayashi, M; Kuwahara, A; Miyahara, M; Saito, T; Shigemitsu, Y; Shimoda, K; Zeze, K | 1 |
Ando, N; Ide, H; Ishida, K; Kakegawa, T; Lizuka, T; Mori, S; Nashimoto, A; Sasaki, K; Takagi, I; Watanabe, H | 1 |
Awano, T; Kinosita, H; Koide, Y; Kouzu, T; Matubara, H; Nakaichi, H; Okuyama, K; Onoda, S; Sano, T; Tohnosu, N | 1 |
Hasegawa, M; Miyashita, K; Muto, T; Sasaki, K; Suzuki, S; Suzuki, T; Tanaka, O | 1 |
Iizuka, T | 1 |
Bertin, F; Elias, D; Eschwege, F; Girinsky, T; Kac, J; Lasser, P; Leclercq, B; Nitenberg, G; Rougier, P; Spielmann, M | 1 |
Bains, M; Coonley, C; Fein, R; Heelan, R; Kelsen, DP | 1 |
Caille, P; Elias, D; Kac, J; Lasser, P; Le Chevalier, T; Rouesse, J; Rougier, P; Spielmann, M; Zummer, K | 1 |
7 review(s) available for vindesine and Esophageal Neoplasms
Article | Year |
---|---|
Adjuvant chemotherapy versus surgery alone for esophageal squamous cell carcinoma: a meta-analysis of randomized controlled trials and nonrandomized studies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Esophageal Neoplasms; Esophagectomy; Fluorouracil; Humans; Lymphatic Metastasis; Neoplasm Staging; Randomized Controlled Trials as Topic; Survival Rate; Vindesine | 2014 |
[Neoadjuvant therapy for resectable esophageal cancer].
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Dose Fractionation, Radiation; Esophageal Neoplasms; Etoposide; Fluorouracil; Humans; Meta-Analysis as Topic; Neoadjuvant Therapy; Postoperative Care; Preoperative Care; Radiotherapy Dosage; Randomized Controlled Trials as Topic; Time Factors; Vindesine | 2005 |
Chemotherapy of esophageal cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Doxorubicin; Esophageal Neoplasms; Etoposide; Fluorouracil; Humans; Lomustine; Methotrexate; Mitoguazone; Mitomycin; Mitomycins; Neoplasm Metastasis; Postoperative Care; Preoperative Care; Vinblastine; Vindesine | 1984 |
Combined-modality therapy of esophageal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Doxorubicin; Esophageal Neoplasms; Esophagus; Fluorouracil; Humans; Methotrexate; Postoperative Care; Preoperative Care; Radiotherapy Dosage; Time Factors; Vinblastine; Vindesine | 1984 |
[Chemotherapy and multimodality therapy in the treatment of esophageal cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Esophageal Neoplasms; Fluorouracil; Humans; Radiotherapy, Adjuvant; Vindesine | 1995 |
[Problems and present status of clinical trials for esophageal carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Esophageal Neoplasms; Humans; Radiotherapy Dosage; Randomized Controlled Trials as Topic; Survival Rate; Vindesine | 1994 |
[Treatment of patients with recurrent esophageal carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Esophageal Neoplasms; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplastic Cells, Circulating; Prognosis; Survival Rate; Vindesine | 1998 |
7 trial(s) available for vindesine and Esophageal Neoplasms
Article | Year |
---|---|
A comparison of chemotherapy and radiotherapy as adjuvant treatment to surgery for esophageal carcinoma. Japanese Esophageal Oncology Group.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Radiotherapy Dosage; Survival Rate; Vindesine | 1993 |
[Surgical adjuvant therapy of carcinoma of the thoracic esophagus].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Radiotherapy Dosage; Survival Rate; Vindesine | 1993 |
A randomized trial of surgery with and without chemotherapy for localized squamous carcinoma of the thoracic esophagus: the Japan Clinical Oncology Group Study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Prospective Studies; Survival Analysis; Vindesine | 1997 |
Preoperative therapy for esophageal cancer: a randomized comparison of chemotherapy versus radiation therapy.
Topics: Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Chi-Square Distribution; Cisplatin; Combined Modality Therapy; Esophageal Neoplasms; Female; Follow-Up Studies; Humans; Male; Middle Aged; Preoperative Care; Randomized Controlled Trials as Topic; Remission Induction; Vindesine | 1990 |
Phase II evaluation of combined cisplatin and vindesine in advanced squamous cell carcinoma of the esophagus: Japanese Esophageal Oncology Group Trial.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Esophageal Neoplasms; Female; Humans; Liver Neoplasms; Male; Middle Aged; Remission Induction; Survival Rate; Vindesine | 1991 |
Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Esophageal Neoplasms; Humans; Postoperative Complications; Random Allocation; Vindesine | 1988 |
Preoperative (neoadjuvant) chemotherapy in squamous cell cancer of the esophagus.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Esophageal Neoplasms; Follow-Up Studies; Humans; Preoperative Care; Vindesine | 1988 |
42 other study(ies) available for vindesine and Esophageal Neoplasms
Article | Year |
---|---|
A retrospective study of second-line chemotherapy for unresectable or recurrent squamous cell carcinoma of the esophagus refractory to chemotherapy with 5-fluorouracil plus platinum.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Docetaxel; Drug Administration Schedule; Drug Resistance, Neoplasm; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Organoplatinum Compounds; Retrospective Studies; Survival Analysis; Taxoids; Treatment Outcome; Vindesine | 2008 |
Combination chemotherapy of esophageal carcinoma using cisplatin, vindesine, and bleomycin.
Topics: Acute Kidney Injury; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Drug Therapy, Combination; Esophageal Neoplasms; Female; Humans; Leukopenia; Male; Vinblastine; Vindesine | 1982 |
Advances in chemotherapy of esophageal cancer.
Topics: Antineoplastic Agents; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Esophageal Neoplasms; Humans; Male; Middle Aged; Palliative Care; Prognosis; Smoking; United States; Vinblastine; Vindesine | 1981 |
Treatment of esophageal carcinoma combined preoperative chemotherapy.
Topics: Adult; Aged; Antineoplastic Agents; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Drug Therapy, Combination; Esophageal Neoplasms; Esophagus; Female; Gastrectomy; Humans; Male; Middle Aged; Neoplasm Metastasis; Prognosis; Vinblastine; Vindesine | 1982 |
Clinical and pathological evaluation of response to chemotherapy in patients with esophageal carcinoma.
Topics: Antineoplastic Agents; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Drug Therapy, Combination; Esophageal Neoplasms; Humans; Neoplasm Staging; Radiography; Vinblastine; Vindesine | 1983 |
Cisplatin, vindesine, and bleomycin chemotherapy of local-regional and advanced esophageal carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Vinblastine; Vindesine | 1983 |
[Combination chemotherapy of nicardipine and vindesine sulfate, cis-diammine dichloroplatinum (II) for patients with advanced esophageal carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Calcium Channel Blockers; Carcinoma, Squamous Cell; Circadian Rhythm; Cisplatin; Drug Administration Schedule; Drug Resistance; Drug Synergism; Esophageal Neoplasms; Female; Humans; Infusions, Parenteral; Male; Middle Aged; Nicardipine; Nifedipine; Vinblastine; Vindesine | 1984 |
[Effect of cis-diammine dichloroplatinum, vindesine sulfate combination chemotherapy for advanced esophageal carcinoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Vinblastine; Vindesine; Vomiting | 1984 |
[A cooperative phase II study of vindesine sulfate in patients with solid tumors].
Topics: Adolescent; Adult; Aged; Breast Neoplasms; Child; Drug Evaluation; Esophageal Neoplasms; Female; Humans; Injections, Intravenous; Lung Neoplasms; Male; Middle Aged; Neoplasms; Vinblastine; Vindesine | 1983 |
Treatment of esophageal cancer with vindesine: an open trial.
Topics: Drug Evaluation; Esophageal Neoplasms; Female; Humans; Leukopenia; Male; Middle Aged; Neoplasm Metastasis; Serum Albumin; Thrombocytopenia; Time Factors; Vinblastine; Vindesine | 1984 |
Neoadjuvant chemotherapy and radiotherapy in locally advanced esophagus carcinoma: long-term results.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Esophageal Neoplasms; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Retrospective Studies; Spain; Survival Analysis; Survival Rate; Time Factors; Vindesine | 1993 |
Cisplatin, vindesine, pepleomycin and combined radiation therapy for inoperable esophageal carcinoma.
Topics: Actuarial Analysis; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Peplomycin; Radiotherapy Dosage; Survival Analysis; Treatment Outcome; Vindesine | 1993 |
[Multidisciplinary treatment of cancer of the esophagus].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Doxorubicin; Drug Administration Schedule; Esophageal Neoplasms; Esophagus; Fluorouracil; Humans; Radiotherapy Dosage; Survival Rate; Vindesine | 1993 |
[Multidisciplinary treatment principles for improved QOL in patients with esophageal cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Esophageal Neoplasms; Humans; Lymph Node Excision; Quality of Life; Radiotherapy Dosage; Thoracotomy; Vindesine | 1993 |
[Effective combined injection method of fluoropyrimidine and platinum--application for advanced esophageal cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Drug Administration Schedule; Esophageal Neoplasms; Female; Fluorouracil; Humans; Injections; Male; Methotrexate; Vinblastine; Vindesine | 1996 |
[Inoperable esophageal carcinoma managed by combined chemotherapy (CBDCA, 5-FU and VDS) and radiotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Catheterization; Combined Modality Therapy; Drug Administration Schedule; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Quality of Life; Radiotherapy Dosage; Survival Rate; Vindesine | 1997 |
An experience of treatment for patients with thoracic esophageal cancer invading adjacent organs.
Topics: Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Aorta; Cisplatin; Combined Modality Therapy; Disease Progression; Disease-Free Survival; Esophageal Neoplasms; Esophagectomy; Humans; Lymph Node Excision; Middle Aged; Neoplasm Invasiveness; Postoperative Complications; Pulmonary Veins; Radiotherapy Dosage; Remission Induction; Survival Rate; Thorax; Trachea; Vena Cava, Superior; Vindesine | 1997 |
[Curative treatment of non-metastatic esophageal cancer: concomitant chemoradiotherapy and high-dose-rate endoluminal curietherapy boost].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Data Interpretation, Statistical; Esophageal Neoplasms; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Prognosis; Radiotherapy Dosage; Time Factors; Vindesine | 1999 |
[A case of stage IV esophageal cancer successfully treated by chemoradiation].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Esophageal Neoplasms; Fluorouracil; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Radiotherapy Dosage; Vindesine | 1999 |
Comparative genomic hybridization study of genetic changes associated with vindesine resistance in esophageal carcinoma.
Topics: Chromosome Aberrations; Chromosomes, Human; Drug Resistance, Neoplasm; Esophageal Neoplasms; Gene Amplification; Gene Dosage; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, Neoplasm; Humans; In Situ Hybridization, Fluorescence; Metaphase; Nucleic Acid Hybridization; Physical Chromosome Mapping; Tumor Cells, Cultured; Vindesine | 2002 |
Different sensitivities of human esophageal cancer cells to multiple anti-cancer agents and related mechanisms.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Northern; Blotting, Western; Carcinoma, Squamous Cell; DNA Topoisomerases, Type II; Drug Resistance; Esophageal Neoplasms; Etoposide; Gene Expression; Glutathione Transferase; Humans; Membrane Glycoproteins; RNA, Neoplasm; Tumor Cells, Cultured; Tumor Stem Cell Assay; Vincristine; Vindesine | 1992 |
Neoadjuvant chemotherapy in multiple synchronous head and neck and esophagus squamous cell carcinomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bronchial Neoplasms; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Esophageal Neoplasms; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Multiple Primary; Retrospective Studies; Treatment Outcome; Vindesine | 1992 |
[Combined radio-chemotherapy of progressive esophageal cancers].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Radiotherapy Dosage; Survival Rate; Tegafur; Vindesine | 1992 |
[Chemotherapy-associated hemolytic uremic syndrome--a case report].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Doxorubicin; Esophageal Neoplasms; Fluorouracil; Hemolytic-Uremic Syndrome; Humans; Male; Middle Aged; Mitomycin; Neoplasms, Multiple Primary; Stomach Neoplasms; Vindesine | 1992 |
[Unresectable stage 4-cancer of the esophagus well responded to combined chemoradiotherapy--a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Esophageal Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Peplomycin; Remission Induction; Vindesine | 1990 |
Subrenal capsule assay as a chemosensitivity test for primary esophageal squamous cell carcinoma.
Topics: Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cell Division; Esophageal Neoplasms; Female; Fluorouracil; Humans; Immunohistochemistry; Mice; Middle Aged; Neoplasm Transplantation; Organoplatinum Compounds; Peplomycin; Subrenal Capsule Assay; Time Factors; Vindesine | 1991 |
[Combination chemotherapy with cis-diamminedichloroplatinum (CDDP) and other anticancer agents for patients with advanced esophageal cancer].
Topics: Adult; Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cisplatin; Drug Administration Schedule; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Nausea; Peplomycin; Vinblastine; Vindesine; Vomiting | 1985 |
The impact of combined therapeutic modalities in head, neck, and esophageal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Esophageal Neoplasms; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Methotrexate; Prognosis; Radiotherapy Dosage; Vindesine | 1985 |
Phase II evaluation of cisplatin, bleomycin, and vindesine in advanced squamous cell carcinoma of the esophagus: a Southeastern Cancer Study Group Trial.
Topics: Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Vindesine | 1986 |
Preoperative chemotherapy in localized cancer of the esophagus with cis-platinum, vindesine and bleomycin.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Vindesine | 1985 |
[Analysis of the chemosensitivity test by subrenal capsule assay].
Topics: Animals; Antineoplastic Agents; Bleomycin; Cisplatin; Colonic Neoplasms; Colony-Forming Units Assay; Doxorubicin; Esophageal Neoplasms; Humans; Mice; Mitomycin; Mitomycins; Peplomycin; Rectal Neoplasms; Stomach Neoplasms; Tumor Stem Cell Assay; Vindesine | 1987 |
[A 6-day subrenal capsule assay for predictive testing of primary esophageal cancers].
Topics: Adult; Aged; Animals; Antineoplastic Agents; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Colony-Forming Units Assay; Drug Evaluation, Preclinical; Esophageal Neoplasms; Female; Humans; Male; Methotrexate; Mice; Middle Aged; Neoplasm Transplantation; Tumor Stem Cell Assay; Vindesine | 1987 |
[Preoperative chemotherapy in esophageal cancer: an advantage or danger for surgical intervention?].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Drug Evaluation; Esophageal Neoplasms; Humans; Postoperative Complications; Risk Factors; Vindesine | 1987 |
[Multidisciplinary treatment of esophageal carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Esophageal Neoplasms; Humans; Methotrexate; Prognosis; Retrospective Studies; Vindesine | 1988 |
[Combined chemoradio (CVPR) therapy in the treatment of inoperable and recurrent esophageal cancer].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Peplomycin; Radiotherapy Dosage; Vindesine | 1988 |
A phase II study of vindesine in the treatment of esophageal carcinoma. Japanese Esophageal Oncology Group.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Combined Modality Therapy; Drug Evaluation; Esophageal Neoplasms; Female; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Remission Induction; Vindesine | 1989 |
[Effects of combined therapy with irradiation, cisplatin and vindesine in lymph node recurrence of esophageal cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Esophageal Neoplasms; Humans; Lymphatic Metastasis; Prognosis; Vindesine | 1989 |
[Remarkable effect of vindesine sulfate (VDS) in the treatment of metachronous lung metastasis of esophageal cancer--a case report].
Topics: Carcinoma, Squamous Cell; Drug Administration Schedule; Esophageal Neoplasms; Esophagus; Humans; Lung Neoplasms; Male; Middle Aged; Postoperative Period; Remission Induction; Vindesine | 1988 |
[Chemotherapy of esophageal carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Esophageal Neoplasms; Fluorouracil; Humans; Vindesine | 1988 |
[Epidermoid cancers of the esophagus: combined chemotherapy, surgery and radiotherapy. Preliminary results in 50 cases].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Prognosis; Vindesine | 1988 |
Cisplatin, vindesine, and mitoguazone in the treatment of esophageal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Esophageal Neoplasms; Female; Humans; Leukopenia; Male; Middle Aged; Mitoguazone; Neoplasm Metastasis; Vindesine | 1986 |
[Combination vindesine, cyclophosphamide, cis-platinum and CCNU in esophageal epidermoid cancer. Preliminary analysis of 64 cases].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Drug Evaluation; Esophageal Neoplasms; Female; Humans; Lomustine; Male; Middle Aged; Vindesine | 1985 |